AstraZeneca sees profits surge and lays out Covid vaccine plans
Covid-19 vaccine maker AstraZeneca (AZN) reported a 10% increase in core revenue and saw profit more than double as new treatments powered performance last year. The pharma giant also updated on developments of its Covid-19 vaccine...
11 February 2021